Connect
← Return to New research on length of ADT therapy for patients with RT
Discussion
New research on length of ADT therapy for patients with RT
Prostate Cancer | Last Active: 3 hours ago | Replies (24)Comment receiving replies
Yes, genAI will either help refine the data or tell me I'll live to age 512. You never know with AI. 🙂
But I agree with you that it can be a useful tool for spotting trends in massive datasets, as long as there's close expert human supervision and review.
Replies to "Yes, genAI will either help refine the data or tell me I'll live to age 512...."
Connect
@northoftheborder
Oh, I am not saying that we should use AI ha ha , no way ! AI will give us at the end what we wish to read and hear if we play with it long enough ! ; ) Unfortunately there is zero education or information for general public about that fact *sigh
I am talking about doctors and researchers using AI for that - same way they use it now for MRI analysis etc. At Stanford they use it to scan mammograms now (I was told that last time I had a mammogram there).
There are big advancements in repurposing old drugs for new treatments and "off label" usage for different conditions for which was no help - AI helped with that. In right hands AI is a fantastic tool, in wrong ones - may lord help us all ....